Multiscale multimodal medical imaging has emerged as a transformative approach in cancer research, revolutionizing our understanding and treatment of the disease. By integrating various imaging techniques such as MRI, CT scans, PET scans, and optical imaging at different scales—from macroscopic to molecular—this approach offers unprecedented insights into tumor development, progression, and response to therapy.
Through a synergistic combination of structural, functional, and molecular imaging modalities, researchers can precisely characterize tumor morphology, vascularization, metabolism, and molecular signatures. This comprehensive assessment not only enhances early detection and accurate diagnosis but also guides personalized treatment strategies, improving patient outcomes. Furthermore, the integration of imaging data with advanced computational models enables predictive modeling of tumor behavior and therapeutic response, paving the way for more effective cancer management.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States